Ocular Immunology and Uveitis Foundation is ranked among medical research organizations in Weston, MA, with an America's Best Score of 77 out of 100, based on its 2024 Form 990.
The Ocular Immunology and Uveitis Foundation is dedicated to improving the diagnosis and treatment and finding the causes and cures of uveitis and other ocular inflammatory diseases, increase awareness of uveitis amoung health professionals and the public, and support individuals and families affected by the disease.
Largest programs · fiscal year 2024
Various research studies and development to promote and carry out scientific and medical research in the field of diseases of the eye.$123,381 spent · 27.6% of program spending
Physician education conference: A comprehensive coverage of new and emerging developments in the subspecialties of cornea, glaucoma, cataract & refractive surgery, oculoplastics, uveitis and infectious disease. The faculty consisted of nineteen ophthalmologists. Physicians from all over new england attended the conference.$267,600 spent · 59.8% of program spending
Support group programs, consists generally of group speakers, educational and support resources.$56,847 spent · 12.7% of program spending
Where each dollar went · fiscal year 2024
Of every dollar it spent, 63¢ went to programs, 11¢ to management and 26¢ to fundraising.
Programs $447,828
Management $72,995
Fundraising $185,973
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
63%
Below
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$1,565,787Fiscal year 2024
Expenses$706,796Fiscal year 2024
Total assets$3,006,646Fiscal year 2024
Total liabilities$3,045Fiscal year 2024
Fiscal year ending December2024
Revenue$1,565,787
Expenses$706,796
Net income$858,991
Net assets$3,003,601
Notable sources of revenue
Percent of total revenue
Contributions
$1,307,421
83.5%
Program services
$0
0.0%
Investment income
$123,939
7.9%
Other (net)
$134,427
8.6%
Assets / debt
Total assets
$3,006,646
Total liabilities
$3,045
Net assets
$3,003,601
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$1,638,698
Expenses$704,660
Net income$934,038
Net assets$2,108,263
Notable sources of revenue
Percent of total revenue
Contributions
$1,512,787
92.3%
Program services
$0
0.0%
Investment income
$13,966
0.9%
Other (net)
$111,945
6.8%
Assets / debt
Total assets
$2,230,654
Total liabilities
$122,391
Net assets
$2,108,263
Compensation
Officers and key employees
$0
Share of expenses
0.0%
Fiscal year ending December2022
Revenue$733,623
Expenses$733,858
Net income−$235
Net assets$1,010,951
Notable sources of revenue
Percent of total revenue
Contributions
$581,728
79.3%
Program services
$0
0.0%
Investment income
$68,519
9.3%
Other (net)
$83,376
11.4%
Assets / debt
Total assets
$1,079,830
Total liabilities
$68,879
Net assets
$1,010,951
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?